Global Nanoparticle-Mediated Delivery Market Research Report 2026(Status and Outlook)
Description
Report Overview
Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.In this report, we only study liposomal/lipid nanoparticle drug delivery system.LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer–BioNTech COVID-19 vaccines).In this report, the COVID-19 vaccines with lipid nanoparticles technologies are not covered. The COVID-19 vaccines launch on the end of 2020. We expect revenue for COVID-19 vaccines with lipid nanoparticles technologies in 2021 to be approximately 37 billion USD.Global Nanoparticle Drug Delivery Systems key players include Gilead Sciences, CSPC, Pacira, Alnylam, etc. Global top four manufacturers hold a share about 37%.Asia-Pacific is the largest market, with a share about 37%, followed by Europe, and North America, both have a share over 56 percent. In terms of product, Liposomes Drugs is the largest segment, with a share over 92%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital, etc.
The global Nanoparticle-Mediated Delivery market size was estimated at USD 4925.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nanoparticle-Mediated Delivery market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nanoparticle-Mediated Delivery market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nanoparticle-Mediated Delivery market.
Global Nanoparticle-Mediated Delivery Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
AbbVie
BlueWillow Biologics
NovaSOL
Camurus
Ceramisphere
Celgene, CytImmune
Cristal Therapeutics
EnColl
Lena Nanoceutics Ltd.
EyePoint Pharmaceuticals
Nanobiotix
NanoCarrier
Nanospectra
NanOlogy
Selecta Biosciences
Parvus Therapeutics
Starpharma
Tarveda Therapeutics
Market Segmentation (by Type)
Biological Origin
Non-Biological Origin
Market Segmentation (by Application)
Drug Delivery
Gene Delivery
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nanoparticle-Mediated Delivery Market
Overview of the regional outlook of the Nanoparticle-Mediated Delivery Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nanoparticle-Mediated Delivery Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nanoparticle-Mediated Delivery, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.In this report, we only study liposomal/lipid nanoparticle drug delivery system.LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer–BioNTech COVID-19 vaccines).In this report, the COVID-19 vaccines with lipid nanoparticles technologies are not covered. The COVID-19 vaccines launch on the end of 2020. We expect revenue for COVID-19 vaccines with lipid nanoparticles technologies in 2021 to be approximately 37 billion USD.Global Nanoparticle Drug Delivery Systems key players include Gilead Sciences, CSPC, Pacira, Alnylam, etc. Global top four manufacturers hold a share about 37%.Asia-Pacific is the largest market, with a share about 37%, followed by Europe, and North America, both have a share over 56 percent. In terms of product, Liposomes Drugs is the largest segment, with a share over 92%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital, etc.
The global Nanoparticle-Mediated Delivery market size was estimated at USD 4925.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nanoparticle-Mediated Delivery market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nanoparticle-Mediated Delivery market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nanoparticle-Mediated Delivery market.
Global Nanoparticle-Mediated Delivery Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
AbbVie
BlueWillow Biologics
NovaSOL
Camurus
Ceramisphere
Celgene, CytImmune
Cristal Therapeutics
EnColl
Lena Nanoceutics Ltd.
EyePoint Pharmaceuticals
Nanobiotix
NanoCarrier
Nanospectra
NanOlogy
Selecta Biosciences
Parvus Therapeutics
Starpharma
Tarveda Therapeutics
Market Segmentation (by Type)
Biological Origin
Non-Biological Origin
Market Segmentation (by Application)
Drug Delivery
Gene Delivery
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nanoparticle-Mediated Delivery Market
Overview of the regional outlook of the Nanoparticle-Mediated Delivery Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nanoparticle-Mediated Delivery Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nanoparticle-Mediated Delivery, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
164 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Nanoparticle-Mediated Delivery
- 1.2 Key Market Segments
- 1.2.1 Nanoparticle-Mediated Delivery Segment by Type
- 1.2.2 Nanoparticle-Mediated Delivery Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Nanoparticle-Mediated Delivery Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Nanoparticle-Mediated Delivery Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Nanoparticle-Mediated Delivery Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Nanoparticle-Mediated Delivery Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Nanoparticle-Mediated Delivery Product Life Cycle
- 3.3 Global Nanoparticle-Mediated Delivery Sales by Manufacturers (2020-2025)
- 3.4 Global Nanoparticle-Mediated Delivery Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Nanoparticle-Mediated Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Nanoparticle-Mediated Delivery Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Nanoparticle-Mediated Delivery Market Competitive Situation and Trends
- 3.8.1 Nanoparticle-Mediated Delivery Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Nanoparticle-Mediated Delivery Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Nanoparticle-Mediated Delivery Industry Chain Analysis
- 4.1 Nanoparticle-Mediated Delivery Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Nanoparticle-Mediated Delivery Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Nanoparticle-Mediated Delivery Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Nanoparticle-Mediated Delivery Market
- 5.7 ESG Ratings of Leading Companies
- 6 Nanoparticle-Mediated Delivery Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Nanoparticle-Mediated Delivery Sales Market Share by Type (2020-2025)
- 6.3 Global Nanoparticle-Mediated Delivery Market Size by Type (2020-2025)
- 6.4 Global Nanoparticle-Mediated Delivery Price by Type (2020-2025)
- 7 Nanoparticle-Mediated Delivery Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Nanoparticle-Mediated Delivery Market Sales by Application (2020-2025)
- 7.3 Global Nanoparticle-Mediated Delivery Market Size (M USD) by Application (2020-2025)
- 7.4 Global Nanoparticle-Mediated Delivery Sales Growth Rate by Application (2020-2025)
- 8 Nanoparticle-Mediated Delivery Market Sales by Region
- 8.1 Global Nanoparticle-Mediated Delivery Sales by Region
- 8.1.1 Global Nanoparticle-Mediated Delivery Sales by Region
- 8.1.2 Global Nanoparticle-Mediated Delivery Sales Market Share by Region
- 8.2 Global Nanoparticle-Mediated Delivery Market Size by Region
- 8.2.1 Global Nanoparticle-Mediated Delivery Market Size by Region
- 8.2.2 Global Nanoparticle-Mediated Delivery Market Size by Region
- 8.3 North America
- 8.3.1 North America Nanoparticle-Mediated Delivery Sales by Country
- 8.3.2 North America Nanoparticle-Mediated Delivery Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Nanoparticle-Mediated Delivery Sales by Country
- 8.4.2 Europe Nanoparticle-Mediated Delivery Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Nanoparticle-Mediated Delivery Sales by Region
- 8.5.2 Asia Pacific Nanoparticle-Mediated Delivery Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Nanoparticle-Mediated Delivery Sales by Country
- 8.6.2 South America Nanoparticle-Mediated Delivery Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Nanoparticle-Mediated Delivery Sales by Region
- 8.7.2 Middle East and Africa Nanoparticle-Mediated Delivery Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Nanoparticle-Mediated Delivery Market Production by Region
- 9.1 Global Production of Nanoparticle-Mediated Delivery by Region(2020-2025)
- 9.2 Global Nanoparticle-Mediated Delivery Revenue Market Share by Region (2020-2025)
- 9.3 Global Nanoparticle-Mediated Delivery Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Nanoparticle-Mediated Delivery Production
- 9.4.1 North America Nanoparticle-Mediated Delivery Production Growth Rate (2020-2025)
- 9.4.2 North America Nanoparticle-Mediated Delivery Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Nanoparticle-Mediated Delivery Production
- 9.5.1 Europe Nanoparticle-Mediated Delivery Production Growth Rate (2020-2025)
- 9.5.2 Europe Nanoparticle-Mediated Delivery Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Nanoparticle-Mediated Delivery Production (2020-2025)
- 9.6.1 Japan Nanoparticle-Mediated Delivery Production Growth Rate (2020-2025)
- 9.6.2 Japan Nanoparticle-Mediated Delivery Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Nanoparticle-Mediated Delivery Production (2020-2025)
- 9.7.1 China Nanoparticle-Mediated Delivery Production Growth Rate (2020-2025)
- 9.7.2 China Nanoparticle-Mediated Delivery Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 AbbVie
- 10.1.1 AbbVie Basic Information
- 10.1.2 AbbVie Nanoparticle-Mediated Delivery Product Overview
- 10.1.3 AbbVie Nanoparticle-Mediated Delivery Product Market Performance
- 10.1.4 AbbVie Business Overview
- 10.1.5 AbbVie SWOT Analysis
- 10.1.6 AbbVie Recent Developments
- 10.2 BlueWillow Biologics
- 10.2.1 BlueWillow Biologics Basic Information
- 10.2.2 BlueWillow Biologics Nanoparticle-Mediated Delivery Product Overview
- 10.2.3 BlueWillow Biologics Nanoparticle-Mediated Delivery Product Market Performance
- 10.2.4 BlueWillow Biologics Business Overview
- 10.2.5 BlueWillow Biologics SWOT Analysis
- 10.2.6 BlueWillow Biologics Recent Developments
- 10.3 NovaSOL
- 10.3.1 NovaSOL Basic Information
- 10.3.2 NovaSOL Nanoparticle-Mediated Delivery Product Overview
- 10.3.3 NovaSOL Nanoparticle-Mediated Delivery Product Market Performance
- 10.3.4 NovaSOL Business Overview
- 10.3.5 NovaSOL SWOT Analysis
- 10.3.6 NovaSOL Recent Developments
- 10.4 Camurus
- 10.4.1 Camurus Basic Information
- 10.4.2 Camurus Nanoparticle-Mediated Delivery Product Overview
- 10.4.3 Camurus Nanoparticle-Mediated Delivery Product Market Performance
- 10.4.4 Camurus Business Overview
- 10.4.5 Camurus Recent Developments
- 10.5 Ceramisphere
- 10.5.1 Ceramisphere Basic Information
- 10.5.2 Ceramisphere Nanoparticle-Mediated Delivery Product Overview
- 10.5.3 Ceramisphere Nanoparticle-Mediated Delivery Product Market Performance
- 10.5.4 Ceramisphere Business Overview
- 10.5.5 Ceramisphere Recent Developments
- 10.6 Celgene, CytImmune
- 10.6.1 Celgene, CytImmune Basic Information
- 10.6.2 Celgene, CytImmune Nanoparticle-Mediated Delivery Product Overview
- 10.6.3 Celgene, CytImmune Nanoparticle-Mediated Delivery Product Market Performance
- 10.6.4 Celgene, CytImmune Business Overview
- 10.6.5 Celgene, CytImmune Recent Developments
- 10.7 Cristal Therapeutics
- 10.7.1 Cristal Therapeutics Basic Information
- 10.7.2 Cristal Therapeutics Nanoparticle-Mediated Delivery Product Overview
- 10.7.3 Cristal Therapeutics Nanoparticle-Mediated Delivery Product Market Performance
- 10.7.4 Cristal Therapeutics Business Overview
- 10.7.5 Cristal Therapeutics Recent Developments
- 10.8 EnColl
- 10.8.1 EnColl Basic Information
- 10.8.2 EnColl Nanoparticle-Mediated Delivery Product Overview
- 10.8.3 EnColl Nanoparticle-Mediated Delivery Product Market Performance
- 10.8.4 EnColl Business Overview
- 10.8.5 EnColl Recent Developments
- 10.9 Lena Nanoceutics Ltd.
- 10.9.1 Lena Nanoceutics Ltd. Basic Information
- 10.9.2 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Product Overview
- 10.9.3 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Product Market Performance
- 10.9.4 Lena Nanoceutics Ltd. Business Overview
- 10.9.5 Lena Nanoceutics Ltd. Recent Developments
- 10.10 EyePoint Pharmaceuticals
- 10.10.1 EyePoint Pharmaceuticals Basic Information
- 10.10.2 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Product Overview
- 10.10.3 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Product Market Performance
- 10.10.4 EyePoint Pharmaceuticals Business Overview
- 10.10.5 EyePoint Pharmaceuticals Recent Developments
- 10.11 Nanobiotix
- 10.11.1 Nanobiotix Basic Information
- 10.11.2 Nanobiotix Nanoparticle-Mediated Delivery Product Overview
- 10.11.3 Nanobiotix Nanoparticle-Mediated Delivery Product Market Performance
- 10.11.4 Nanobiotix Business Overview
- 10.11.5 Nanobiotix Recent Developments
- 10.12 NanoCarrier
- 10.12.1 NanoCarrier Basic Information
- 10.12.2 NanoCarrier Nanoparticle-Mediated Delivery Product Overview
- 10.12.3 NanoCarrier Nanoparticle-Mediated Delivery Product Market Performance
- 10.12.4 NanoCarrier Business Overview
- 10.12.5 NanoCarrier Recent Developments
- 10.13 Nanospectra
- 10.13.1 Nanospectra Basic Information
- 10.13.2 Nanospectra Nanoparticle-Mediated Delivery Product Overview
- 10.13.3 Nanospectra Nanoparticle-Mediated Delivery Product Market Performance
- 10.13.4 Nanospectra Business Overview
- 10.13.5 Nanospectra Recent Developments
- 10.14 NanOlogy
- 10.14.1 NanOlogy Basic Information
- 10.14.2 NanOlogy Nanoparticle-Mediated Delivery Product Overview
- 10.14.3 NanOlogy Nanoparticle-Mediated Delivery Product Market Performance
- 10.14.4 NanOlogy Business Overview
- 10.14.5 NanOlogy Recent Developments
- 10.15 Selecta Biosciences
- 10.15.1 Selecta Biosciences Basic Information
- 10.15.2 Selecta Biosciences Nanoparticle-Mediated Delivery Product Overview
- 10.15.3 Selecta Biosciences Nanoparticle-Mediated Delivery Product Market Performance
- 10.15.4 Selecta Biosciences Business Overview
- 10.15.5 Selecta Biosciences Recent Developments
- 10.16 Parvus Therapeutics
- 10.16.1 Parvus Therapeutics Basic Information
- 10.16.2 Parvus Therapeutics Nanoparticle-Mediated Delivery Product Overview
- 10.16.3 Parvus Therapeutics Nanoparticle-Mediated Delivery Product Market Performance
- 10.16.4 Parvus Therapeutics Business Overview
- 10.16.5 Parvus Therapeutics Recent Developments
- 10.17 Starpharma
- 10.17.1 Starpharma Basic Information
- 10.17.2 Starpharma Nanoparticle-Mediated Delivery Product Overview
- 10.17.3 Starpharma Nanoparticle-Mediated Delivery Product Market Performance
- 10.17.4 Starpharma Business Overview
- 10.17.5 Starpharma Recent Developments
- 10.18 Tarveda Therapeutics
- 10.18.1 Tarveda Therapeutics Basic Information
- 10.18.2 Tarveda Therapeutics Nanoparticle-Mediated Delivery Product Overview
- 10.18.3 Tarveda Therapeutics Nanoparticle-Mediated Delivery Product Market Performance
- 10.18.4 Tarveda Therapeutics Business Overview
- 10.18.5 Tarveda Therapeutics Recent Developments
- 11 Nanoparticle-Mediated Delivery Market Forecast by Region
- 11.1 Global Nanoparticle-Mediated Delivery Market Size Forecast
- 11.2 Global Nanoparticle-Mediated Delivery Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Nanoparticle-Mediated Delivery Market Size Forecast by Country
- 11.2.3 Asia Pacific Nanoparticle-Mediated Delivery Market Size Forecast by Region
- 11.2.4 South America Nanoparticle-Mediated Delivery Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Nanoparticle-Mediated Delivery by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Nanoparticle-Mediated Delivery Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Nanoparticle-Mediated Delivery by Type (2026-2035)
- 12.1.2 Global Nanoparticle-Mediated Delivery Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Nanoparticle-Mediated Delivery by Type (2026-2035)
- 12.2 Global Nanoparticle-Mediated Delivery Market Forecast by Application (2026-2035)
- 12.2.1 Global Nanoparticle-Mediated Delivery Sales (K Units) Forecast by Application
- 12.2.2 Global Nanoparticle-Mediated Delivery Market Size (M USD) Forecast by Application (2026-2035)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
